Yuriy Kotsurovskyy

Internal Medicine

945 N 12th St
Milwaukee, WI 53233

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Response to Yu, Wang, and Ge.

Response to Yu, Wang, and Ge.

Journal: Journal of the National Cancer Institute

Published: April 19, 2026

Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer.

Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer.

Journal: JCO oncology practice

Published: December 11, 2025

The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer.

The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer.

Journal: Cancer

Published: September 04, 2025

Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.

Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.

Journal: Journal of the National Cancer Institute

Published: August 06, 2025

Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer.

Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer.

Journal: Cancer

Published: July 23, 2025

Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings.

Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings.

Journal: International journal of cancer

Published: July 21, 2025

Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancer.

Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancer.

Journal: Breast cancer research and treatment

Published: May 02, 2025

Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer.

Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer.

Journal: NPJ breast cancer

Published: April 30, 2025

Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study.

Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study.

Journal: JCO clinical cancer informatics

Published: February 14, 2025

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer.

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer.

Journal: Journal of the National Cancer Institute

Published: December 05, 2024

Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancer.

Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancer.

Journal: International journal of cancer

Published: November 01, 2024

Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer.

Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer.

Journal: JCO clinical cancer informatics

Published: April 18, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026